Every cognitive ingredient has "studies" behind it, but studies vary enormously in quality, and marketing rarely distinguishes a large human trial from a promising result in a petri dish. Here is the plain-English framework we use to grade evidence, so you can apply the same skepticism to any product.

This is educational and is not medical advice. Evidence grades are a conservative reading of the research for an ingredient's studied role, not product claims or a promise of effect.

Four questions to ask about any ingredient

  • Is there human evidence, or only lab and animal data? Animal and test-tube results are hypotheses, not proof of a human benefit.
  • Was the studied dose realistic, and does the product match it? A real effect at 300 mg says nothing about a 30 mg sprinkle.
  • Is the effect acute (same day) or cumulative (weeks of daily use)? Both can be valid, but they are different promises.
  • How large and consistent is the effect? Small, mixed, or single-study results deserve caution, not confidence.
This is the plain-English version. For the full rubric we actually apply (study type, replication, population match, dose adequacy, and conflict-of-interest checks), see the Evidence Standard. Read the Evidence Standard

The four grades we use

  • Grade A (strong): multiple human trials with consistent effects.
  • Grade B (moderate): several human trials, with some mixed results.
  • Grade C (limited): early or small human trials.
  • Emerging: mostly preclinical or preliminary human data.

Why almost nothing earns an A

In the stimulant-free cognitive space, honest grading tops out at B for most ingredients. Genuinely strong, consistent, multi-trial human evidence for a same-day cognitive lift is rare outside of stimulants like caffeine. When a brand grades everything it sells as "clinically proven" or implies an A across the board, that is usually grade inflation, and it quietly undermines the few claims that are actually well supported.

Building a cleaner stack? The Clean Focus Stack Guide is free when you join the Signal State waitlist. Get the guide

Applying it in practice

L-theanine and Bacopa monnieri, for example, sit at a defensible B: several human trials, modest and specific effects. Lion's Mane, by contrast, is honestly Emerging: interesting early work, but a thin human evidence base. Neither framing is an attack or an endorsement; it is just calibrating your expectations to what the research actually supports. That calibration, not hype in either direction, is the whole point.

References

This article draws on the primary human research below; see the linked studies for full methods and doses.

  • Calabrese C, Gregory WL, Leo M, et al. "Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly." Journal of Alternative and Complementary Medicine, 2008;14(6):707–713. PMID: 18611150.
  • Laws KR, Sweetnam H, Kondel TK. "Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis." Human Psychopharmacology, 2012;27(6):527–533. PMID: 23001963.